Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Baird Medical Investment Holdings (BDMD) Intangibles (2023 - 2025)

Historic Intangibles for Baird Medical Investment Holdings (BDMD) over the last 3 years, with Q2 2025 value amounting to $12631.0.

  • Baird Medical Investment Holdings' Intangibles changed N/A to $12631.0 in Q2 2025 from the same period last year, while for Jun 2025 it was $12631.0, marking a year-over-year change of. This contributed to the annual value of $16528.0 for FY2024, which is 3513.09% down from last year.
  • Latest data reveals that Baird Medical Investment Holdings reported Intangibles of $12631.0 as of Q2 2025.
  • Over the past 5 years, Baird Medical Investment Holdings' Intangibles peaked at $25479.0 during Q4 2023, and registered a low of $12631.0 during Q2 2025.
  • Moreover, its 3-year median value for Intangibles was $16528.0 (2024), whereas its average is $18212.7.
  • The largest annual percentage gain for Baird Medical Investment Holdings' Intangibles in the last 5 years was 3513.09% (2024), contrasted with its biggest fall of 3513.09% (2024).
  • Baird Medical Investment Holdings' Intangibles (Quarter) stood at $25479.0 in 2023, then tumbled by 35.13% to $16528.0 in 2024, then decreased by 23.58% to $12631.0 in 2025.
  • Its Intangibles stands at $12631.0 for Q2 2025, versus $16528.0 for Q4 2024 and $25479.0 for Q4 2023.